Bumper Offer - Urjas oil Just @ Rs. 1
Cyptan Syrup is a commercial drug that is prescribed in the form of Syrup. It is typically used for the treatment of Anorexia Nervosa, Loss of appetite. Cyptan Syrup also has some secondary and off-label uses. These are listed below.
The optimal dosage of Cyptan Syrup is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Cyptan Syrup can also lead to other problems, which have been listed below. Normally, these side effects of Cyptan Syrup are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Cyptan Syrup has a Safe effect for pregnant women and Moderate effect on lactating mothers. In addition, Cyptan Syrup's effects on the liver, heart and kidney are discussed below in the Cyptan Syrup related warnings section.
Individuals suffering from medical conditions like Peptic Ulcer must refrain from the use of Cyptan Syrup since this can cause severe adverse effects. The section on Cyptan Syrup contraindications lists all such conditions.
Drug reaction of Cyptan Syrup with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Cyptan Syrup is considered not safe while driving, and is not addictive.
Cyptan Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Cyptan Syrup is used -
Moderate
Mild
Is the use of Cyptan Syrup safe for pregnant women?
Cyptan is safe for pregnant women.
Is the use of Cyptan Syrup safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Cyptan. Immediately discontinue Cyptan if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Cyptan Syrup on the Kidneys?
There are no side effects of Cyptan on the kidneys.
What is the effect of Cyptan Syrup on the Liver?
Cyptan may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Cyptan Syrup on the Heart?
Cyptan is rarely harmful for the heart.
Cyptan Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cyptan Syrup unless your doctor advises you to do so -
Is this Cyptan Syrup habit forming or addictive?
Cyptan Syrup is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cyptan Syrup you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Cyptan Syrup is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Cyptan Syrup cannot treat any kind of mental disorder.
Interaction between Food and Cyptan Syrup
Taking Cyptan Syrup with food does not cause any problems.
Interaction between Alcohol and Cyptan Syrup
Consult your doctor before consuming alcohol while taking Cyptan Syrup as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyproheptadine HCI
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 174
